Medtep, a cutting-edge online solution that brings digital therapeutics to disease prevention, treatment and wellness, announced today it has raised $2 million in seed funding. The funding round has been led by the Mexican Investment Fund Stella Maris Partners with the participation of other American and Spanish investors and business angels. The startup will use the fresh capital to ensure its internationalization strategy, focusing on the USA, LatAm and Europe.
Medtep was founded in 2011 in Barcelona. I met the founders twice. The first time was right after they had started. I was impressed by their expertise and ambitions and quite sure they’re on their road to success! A few weeks ago the team moved to San Francisco and celebrated its 4th birthday.
Today, Medtep has more than 20 large international contracts with key stakeholders in the sector. In the last trimester, Medtep reached more than 100,000 users who use its two sided platform to take control of their treatment and wellness by keeping track of different follow-up plans defined by healthcare professionals and personally adapted to users’ condition.
Medtep helps people understand the consequences of poor compliance by showing the real effect of their daily habits, personalized to their situation. Their solution adapts to the specific and temporary conditions of the patient, fostering a behavioral change and improving the treatment compliance. Medtep complements and aggregates today’s medical histories, apps, sensors and devices—to unify and provide meaning to medical and lifestyle-related data.
“This funding is a huge pledge of confidence in Medtep’s vision, as well as in the long term potential of our company” said Pablo Pantaleoni CEO of Medtep. “This capital gives us additional resources to expand quickly and strategically, especially in the USA and LatAm. We will be able to develop our roadmap rapidly and deliver our vision among patients and users around the world”.
